Skip to content
OpenCapital
Get started

AtriCure ATRC Remainder of 2026

Remainder of 2026 at other companies

Abbott logo
AbbottABT
——
Medtronic logo
MedtronicMDT
——
ITG
Integer HoldingsITGR
——
Avanos Medical logo
Avanos MedicalAVNS
——
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
——

Other financials

Income statement

See full
Revenue$141.2M+14.3%
Gross profit$109.3M+18.0%
Operating income$526.0K+109%
Net income$108.0K+102%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$146.2M+46.3%
Total debt$76.2M-3.1%
Total equity$491.7M+8.2%
Total assets$644.0M+8.8%

Cash flow

See full
Operating cash flow-$4.0M+63.8%
CapEx$3.9M+76.6%
Free cash flow-$7.8M+40.6%

Valuation

See full
Market cap$1.43B-7.9%
Enterprise value$1.36B-11.2%
P/S2.6×-0.6×

Profitability

See full
Gross margin75.6%+0.8pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.7%—

Returns & leverage

See full
Return on equity-6.1%-1.3pp
Debt / equity0.2×0.0×
Current ratio4.3×+0.2×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear.

The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's remainder of 2026.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AtriCure's remainder of 2026?
AtriCure (ATRC) reported remainder of 2026 of $7.15M in Q1 2026.
How has AtriCure's remainder of 2026 changed year-over-year?
AtriCure's remainder of 2026 increased by 13.0% year-over-year, from $6.33M to $7.15M.